Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease

Robert H. Broyles, PhD, Professor/ASH Member, Sunil K. Joshi, PhD BS, DVM, MS, Carol D. Curtis, PhD, Austin C. Roth, B.A., Patrick A. Floyd, Marie Trudel, DSc, Visar Belegu, PhD, Ashley A. Baker, MD, Robert A.. Floyd, PhD

Blood (2014) 124 (21): 1357.

https://doi.org/10.1182/blood.V124.21.1357.1357

Published: 2014

Journal Articles

Ferritin-H and a Phytotherapeutic, Alone or Combined, Reprogram RBC Precursor Cells From SCD Patients to Produce Levels of Fetal Hemoglobin That Constitute a Phenotypic Cure for Sickle Cell As Well As Providing Resistance to Malaria and a Probable Treatment for Beta-Thalassemia

Robert H. Broyles, PhD, Visar Belegu, Ph.D., Austin C. Roth, B.A., Emily J. Curry, B.S., Robert A. Floyd, Ph.D., Sonia Levi, Ph.D., Paolo Arosio, Ph.D., Paolo Santambrogio, Ph.D., Marie Trudel, DSc, Sunil K. Joshi, Ph.D., D.V.M/

Blood (2011) 118 (21): 903.

https://doi.org/10.1182/blood.V118.21.903.903

Published: 2011

Journal Articles

Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients.

Robert H. Broyles, PhD, Visar Belegu, Ph.D., Austin C. Roth, B.S., Emily J. Clarkson, B.S., Kelly S. Williamson, M.S., Charles A. Stewart, Ph.D., Quentin N. Pye, M.S., Robert A. Floyd, Ph.D., Klodiana Jani, Ph.D., Marie Trudel, D.Sc., Paolo Santambrogio, Ph.D., Sonia Levi, Ph.D., Paolo Arosio, Ph.D., Joan Parkhurst Cain, M.D.

Blood (2006) 108 (11): 790.

https://doi.org/10.1182/blood.V108.11.790.790

Published: 2006

Journal Articles

Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse β Major -Globin Promoter.

Robert H. Broyles, Ph.D., Visar Belegu, Ph.D., Charles A. Stewart, Ph.D., Quentin N. Pye, M.S., Austin C. Roth, B.S., Katharine M. Harris, M.S., Robert A. Floyd, Ph.D., Klodianna Jani, Ph.D., Marie Trudel, Ph.D.

Blood (2004) 104 (11): 1223.

https://doi.org/10.1182/blood.V104.11.1223.1223

Published: 2004

Journal Articles

Glycoprotein-180 deficiency: genetics and abnormal neutrophil activation

SJ Weisman, RL Berkow, G Plautz, M Torres, WA McGuire, TD Coates, RA Haak, A Floyd, R Jersild, RL Baehner

Blood (1985) 65 (3): 696–704.

https://doi.org/10.1182/blood.V65.3.696.696

Published: 1985

NARROW

Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease

Ferritin-H and a Phytotherapeutic, Alone or Combined, Reprogram RBC Precursor Cells From SCD Patients to Produce Levels of Fetal Hemoglobin That Constitute a Phenotypic Cure for Sickle Cell As Well As Providing Resistance to Malaria and a Probable Treatment for Beta-Thalassemia

Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients.

Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse β Major -Globin Promoter.

Glycoprotein-180 deficiency: genetics and abnormal neutrophil activation

Email alerts

ASH Publications

American Society of Hematology

Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease

Ferritin-H and a Phytotherapeutic, Alone or Combined, Reprogram RBC Precursor Cells From SCD Patients to Produce Levels of Fetal Hemoglobin That Constitute a Phenotypic Cure for Sickle Cell As Well As Providing Resistance to Malaria and a Probable Treatment for Beta-Thalassemia

Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients.

Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse β Major -Globin Promoter.

Glycoprotein-180 deficiency: genetics and abnormal neutrophil activation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only